检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
出 处:《青岛医药卫生》2011年第1期5-6,共2页Qingdao Medical Journal
摘 要:目的观察奥沙利铂(L—OHP)联合5-氟尿嘧啶(5-Fu)、醛氢叶酸钙(CF)方案时辰给药治疗晚期胃癌的疗效和不良反应。方法采用L-OHP/CF/5-FU时辰方案治疗63例晚期初治胃癌患者,L-OHP35mg/(m^2·d),5-Fu500mg/(m^2·d),CF200mg/d。L—OHP给药时间为10:00-22:00,持续输注12h,给药高峰16:00;5-Fu、CF每天给药时间为22:00一次日10:00,持续输注12h,给药高峰凌晨4:00,连续给药4d。每21d为1个周期,至少用2个周期。结果全组患者共完成346个周期化疗,可评价疗效53例。其中完成6个周期47例,4个周期16例。CR2例(3.77%),PR27例(50.94%),SD10例(18.88%),PD14例(26.42%),总有效率(CR+PR)54.72%。TTP为6.5月(2~52月),中位生存时间为9.8月(4~60月)。最常见的不良反应为血液学毒性、外周神经毒性、胃肠道毒性,但均以I度为主,未出现严重不良反应。结论L—OHP/CF/5-FU时辰方案是晚期胃癌的有效方案,与常规给药方法相比,有可能进一步提高疗效,降低化疗的毒副反应,提高患者的生活质量,值得临床推广使用。Objective To investigate the efficacy and safety of combination of oxaliplatin,5-fluorouracil and folonic acid(L-OHP/CF/5-FU) in form of chronotherapy for advanced gastric cancer. Methods 63 cases patients with advanced gastric cancer received L-OHP/CF/5-FU regimen by multichannel, programmable pumps. Oxaliplatin was given in 35 mg/(m2 · d), from 10:00 to 22:00, peak at 16:00,dl-4; Both 5-FU 500 mg/(m2 · d) and CF 200mg/d were given from 22:00 to 10:00, peak at 4.00 dl-4; ,Every 21 days was one cycle, each case received at least 2 cycles. Results 2 complete and 27 partial remissions were observed in all 53 patients with overall response rate of 54.72%. Stable disease was observed in 10 patients(18.88%) and progressive disease in 14 patients(26.42%). The median Time-To-Progress was 6.5 months(2-52 months) and the median overall survival time was 9.8 months(4-60 months). The main toxicity included myelosuppression, neurotoxicity and nausea/vomiting. Most of them were grade I . Conclusion Chronotberapy with oxaliplatin, 5-fluorouracil and folonic acid is effective and safe in advanced gastric cancer. It may be applied to extensive patients for better quality of life.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.80